Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,288,389
+$98,944 QoQ
Shares Held
5,073
+4.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.27%
of 13F equity value
Holder Rank
#2,755
of 4,676 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LeConte Wealth Management, LLC holds $5,908,077 across 8 Drug Manufacturers - General names. JNJ ranks #2 (21.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
7,085 | $1,782,869 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
5,073 | $1,288,389 | |
| 3 | LLY |
ELI LILLY & Co
|
1,044 | $1,252,205 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,289 | $551,136 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,468 | $311,807 | |
| 6 | AMGN |
Amgen Inc
|
840 | $304,180 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,764 | $216,881 | |
| 8 | PFE |
Pfizer Inc
|
8,331 | $200,610 |
All Filings in JNJ
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,288,389 | 5,073 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,189,445 | 4,866 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $985,495 | 4,762 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $817,145 | 4,407 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $543,026 | 3,555 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $467,337 | 2,818 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||